| 摘要 |
Use of a hydrogel formulation consisting essentially of (i) one or more gelling agents; (ii) water; (iii) optionally a pH-adjusting agent; (iv) optionally a plasticizer; and (v) optionally a surfactant; for the manufacture of a medicament for the treatment of distal inflammatory bowel diseases, in particular for the rectal treatment of ulcerative colitis. This novel use is advantageous in that no local anaesthetics or other active ingredients are required in order to achieve satisfactory relief upon treatment. |
